Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Strauss, S. Geron trial resumes, but standards for stem cell trials remain elusive. Nat Biotechnol 28, 989–990 (2010). https://doi.org/10.1038/nbt1010-989
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1010-989
- Springer Nature America, Inc.
This article is cited by
-
Technical approaches to induce selective cell death of pluripotent stem cells
Cellular and Molecular Life Sciences (2017)
-
Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems
Reproductive Biology and Endocrinology (2015)
-
Tracking gene and cell fate for therapeutic gain
Nature Materials (2014)
-
Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies
Nature Medicine (2013)
-
Embryonic stem cell pioneer Geron exits field, cuts losses
Nature Biotechnology (2012)